LNSR logo

LENSAR (LNSR)

Profile

Full Name

LENSAR, Inc.

Ticker Symbol

LNSR

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 2, 2020

Indexes

Not included

Website

http://www.lensar.com

Employees

140

Key Details

Price

$13.75(+1.85%)

Market cap

$162.11M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$53.49M(+26.87% YoY)

Annual EPS

-$2.73(-108.40% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.75
LNSR price is $13.75

30-Day Relative Volume

0.58
LNSR 30-day relative volume is 0.58

Price Performance

Price Today change

+1.85%
LNSR price is up +1.85% today

Price YTD change

+53.8%
LNSR price is up +53.8% since January 1st

Price 1-year change

+355.3%
LNSR price is up +355.3% year-on-year

Price 3-year change

+85.06%
LNSR price is up +85.06% over the past 3 years

Price Range

Price All-time high

$17.31
LNSR price is currently -20.57% below its historical high of $17.31

Price 3-year low

$1.80
LNSR price is currently +663.89% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$162.11M
LNSR market capitalization is $162.11 million

Market cap 3-year change

+98.62%
LNSR market capitalization is up +98.62% over the past 3 years

Market cap All-time high

$200.42M
LNSR market capitalization is currently -19.12% below its historical high of $200.42 million

Market cap sector rank

54.85%
LNSR market capitalization is higher than 54.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.46%
LNSR shares outstanding is up +3.46% year-on-year

Shares Outstanding 3-Year Change

+7.33%
LNSR shares outstanding is up +7.33% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.63
LNSR beta is 0.63

200-day SMA

$7.87
LNSR price is currently +74.69% above its 200-day simple moving average

50-day SMA

$13.01
LNSR price is currently +5.72% above its 50-day simple moving average

RSI

50.85
LNSR 14-day relative strength index is 50.85

Volume

0.58
LNSR 30-day relative volume is 0.58

ATR

$0.60
LNSR average true range is $0.60

10-day Historical Volatility

23.67%
LNSR 10-day historical volatility is 23.67%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$53.49M
LNSR annual revenue is $53.49 million

Revenue Analysts estimate

$68.15M
LNSR annual revenue is currently -21.51% lower than the consensus analysts' forecast

Revenue 1-year change

+26.87%
LNSR annual revenue is up +26.87% year-on-year

Revenue Sector rank

47.71%
LNSR annual revenue is higher than 47.71% of companies in Healthcare sector

EPS

EPS

-$2.73
LNSR annual earnings per share is -$2.73

EPS Analysts estimate

-$0.39
LNSR annual earnings per share is currently +600.00% higher than the consensus analysts' forecast

EPS 1-year change

-108.4%
LNSR annual earnings per share is down -108.4% year-on-year

EPS Sector rank

32.15%
LNSR annual earnings per share is higher than 32.15% of companies in Healthcare sector

Profit

Gross profit

$25.85M
LNSR annual gross profit is $25.85 million

Gross margin

48.33%
LNSR annual gross profit margin is 48.33%

Operating profit

-$6.94M
LNSR annual operating income is -$6.94 million

Operating margin

-12.97%
LNSR annual operating profit margin is -12.97%

Net income

-$31.40M
LNSR annual net profit is -$31.40 million

Net margin

-58.71%
LNSR annual net profit margin is -58.71%

Expenses

Total expenses

$60.43M
LNSR annual total expenses is $60.43 million

Operating expenses

$32.79M
LNSR annual total operating expenses is $32.79 million

Cost of goods sold

$27.64M
LNSR annual cost of goods sold is $27.64 million

Selling, general & administrative expenses

$26.49M
LNSR annual SGA is $26.49 million

Depreciation and amortization

$3.93M
LNSR annual depreciation & amortization is $3.93 million

Interest expense

-
LNSR annual interest expense value is unknown

Income tax

-
LNSR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$6.94M
LNSR annual earnings before interest & taxes is -$6.94 million

EBITDA

-$3.00M
LNSR annual EBITDA is -$3.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$66.30M
LNSR annual total assets is $66.30 million

Non current assets

$24.32M
LNSR annual long term assets is $24.32 million

Current assets

$41.98M
LNSR annual total current assets is $41.98 million

Cash and cash equivalents

$16.26M
LNSR annual cash & cash equivalents is $16.26 million

Accounts receivable

$6.08M
LNSR annual accounts receivable is $6.08 million

Inventory

$11.43M
LNSR annual inventory is $11.43 million

Liabilities

Total liabilities

$61.44M
LNSR annual total liabilities is $61.44 million

Long term liabilities

$46.43M
LNSR annual total long term liabilities is $46.43 million

Current liabilities

$15.00M
LNSR annual total current liabilities is $15.00 million

Accounts payable

$6.00M
LNSR annual accounts payable is $6.00 million

Debt

Total debt

$2.61M
LNSR annual total debt is $2.61 million

Total debt 1-year change

+13.21%
LNSR annual total debt is up +13.21% year-on-year

Long term debt

$2.09M
LNSR annual long term debt is $2.09 million

Short term debt

$524.00K
LNSR annual short term debt is $524.00 thousand

Equity & Capital

Shareholders equity

$4.86M
LNSR annual stockholders equity is $4.86 million

Book value

$4.86M
LNSR annual book value is $4.86 million

Retained earnings

-$143.29M
LNSR annual retained earnings is -$143.29 million

Working capital

$26.98M
LNSR annual working capital is $26.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.27M
LNSR annual cash flow from operations is -$2.27 million

Cash from operations 1-year change

+76.45%
LNSR annual cash flow from operations is up +76.45% year-on-year

Cash from investing

-$2.16M
LNSR annual cash flow from investing activities is -$2.16 million

Cash from investing 1-year change

+48%
LNSR annual cash flow from investing activities is up +48% year-on-year

Cash from financing

$78.00K
LNSR annual cash flow from financing activities is $78.00 thousand

Cash from financing 1-year change

-99.61%
LNSR annual cash flow from financing activities is down -99.61% year-on-year

CAPEX

CAPEX

$156.00K
LNSR annual capital expenditures is $156.00 thousand

CAPEX 1-year change

-33.9%
LNSR annual capital expenditures is down -33.9% year-on-year

Free Cash Flow

Free cash flow

-$2.43M
LNSR annual free cash flow is -$2.43 million

Free cash flow 1-year change

+75.43%
LNSR annual free cash flow is up +75.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

48.33%
LNSR annual gross profit margin is 48.33%

Operating margin

-12.97%
LNSR annual operating profit margin is -12.97%

Net margin

-58.71%
LNSR annual net profit margin is -58.71%

ROA & ROE

ROA

-46.22%
LNSR annual return on assets is -46.22%

ROE

-164.03%
LNSR annual return on equity is -164.03%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LNSR price to earnings ratio value is unknown

PE ratio Sector rank

-
LNSR price to earnings ratio is unknown

PB Ratio

PB ratio

33.34
LNSR price to book ratio is 33.34

PB ratio Sector rank

97.86%
LNSR price to book ratio is higher than 97.86% of companies in Healthcare sector

PS Ratio

PS ratio

3.03
LNSR price to sales ratio is 3.03

PS ratio Sector rank

52.82%
LNSR price to sales ratio is higher than 52.82% of companies in Healthcare sector

Enterprise value

Enterprise value

$148.46M
LNSR enterprise value is $148.46 million

Enterprise value Sector rank

54.43%
LNSR enterprise value is higher than 54.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-49.40
LNSR EV/EBITDA is -49.40

EV/EBITDA Sector rank

2.61%
LNSR EV/EBITDA is higher than 2.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.80
LNSR annual current ratio is 2.80

Quick ratio

2.04
LNSR annual quick ratio is 2.04

Leverage

Debt to equity

0.00
LNSR annual debt to equity ratio is 0.00

Interest coverage ratio

-
LNSR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
LNSR piotroski f-score is 2

Altman Z-Score

-0.49
LNSR altman z-score is -0.49

Analyst ratings

Recent major analysts updates

Mar 24, 25 Lake Street
Hold
Feb 28, 25 Lake Street
Buy
Mar 19, 24 Lake Street
Buy
Nov 22, 21 BTIG
Buy
Feb 24, 21 SVB Leerink
Outperform

Institutional Ownership

Similar stocks

RZLT logo
Rezolute (RZLT)
IPHA logo
Innate Pharma SA (IPHA)
CGC logo
Canopy Growth (CGC)
MASS logo
908 Devices (MASS)
BWAY logo
BrainsWay (BWAY)
JYNT logo
Joint (JYNT)
NBTX logo
Nanobiotix SA (NBTX)
CYBN logo
Cybin (CYBN)
Actuate Therapeutics (ACTU)
  • What is the ticker symbol for LENSAR?
  • Does LENSAR pay dividends?
  • What sector is LENSAR in?
  • What industry is LENSAR in?
  • What country is LENSAR based in?
  • When did LENSAR go public?
  • Is LENSAR in the S&P 500?
  • Is LENSAR in the NASDAQ 100?
  • Is LENSAR in the Dow Jones?
  • When was LENSAR's last earnings report?
  • When does LENSAR report earnings?
  • Should I buy LENSAR stock now?

What is the ticker symbol for LENSAR?

The ticker symbol for LENSAR is NASDAQ:LNSR

Does LENSAR pay dividends?

No, LENSAR does not pay dividends

What sector is LENSAR in?

LENSAR is in the Healthcare sector

What industry is LENSAR in?

LENSAR is in the Medical Devices industry

What country is LENSAR based in?

LENSAR is headquartered in United States

When did LENSAR go public?

LENSAR's initial public offering (IPO) was on October 2, 2020

Is LENSAR in the S&P 500?

No, LENSAR is not included in the S&P 500 index

Is LENSAR in the NASDAQ 100?

No, LENSAR is not included in the NASDAQ 100 index

Is LENSAR in the Dow Jones?

No, LENSAR is not included in the Dow Jones index

When was LENSAR's last earnings report?

LENSAR's most recent earnings report was on Feb 27, 2025

When does LENSAR report earnings?

The next expected earnings date for LENSAR is May 9, 2025

Should I buy LENSAR stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page